Mutual Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,998
Closed -$862K 1177
2025
Q1
$862K Buy
42,998
+31,932
+289% +$605K 0.02% 502
2024
Q4
$199K Sell
11,066
-1,707
-13% -$32.8K 0.01% 1029
2024
Q3
$252K Buy
+12,773
New +$254K 0.01% 970
2023
Q4
Sell
-37,418
Closed -$743K 1011
2023
Q3
$743K Buy
37,418
+1,037
+3% +$19.6K 0.03% 497
2023
Q2
$683K Buy
36,381
+11,799
+48% +$238K 0.03% 545
2023
Q1
$501K Buy
+24,582
New +$495K 0.02% 617

Other funds holding BTAL

Mutual Advisors's BTAL Position: Q2 2025 in Review

Mutual Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 42,998 shares — an estimated $862K sold.

Mutual Advisors first reported a position in BTAL in Q1 2023 and held it in 6 quarters. The position peaked at $862K in Q1 2025. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.

  • Mutual Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
  • Mutual Advisors sold 42,998 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $862K.
  • Mutual Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 6 quarters.
  • Mutual Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $862K in Q1 2025.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.

Based on Mutual Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.